tiprankstipranks
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
US Market

Cellectar Biosciences (CLRB) Income Statement

Compare
1,320 Followers

Cellectar Biosciences Income Statement

Last quarter (Q3 2024), Cellectar Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cellectar Biosciences's net income was $-14.66M. See Cellectar Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -192.38K$ -238.87K$ -227.64K$ -207.93K
Operating Expenses
$ 51.78M$ 38.96M$ 28.81M$ 24.13M$ 15.29M
Depreciation and Amortization
$ 0.00$ 192.38K$ 238.87K$ 227.64K$ 207.93K
EBITDA
$ -51.78M$ -38.77M$ -28.67M$ -23.98M$ -15.15M
Operating Income
$ -51.78M$ -38.96M$ -28.81M$ -24.13M$ -15.29M
Other Income/Expenses
$ 7.26M$ 917.15K$ 152.52K$ 8.92K$ 196.18K
Pretax Income
$ -44.52M$ -38.04M$ -28.66M$ -24.12M$ -15.09M
Net Income
$ -44.58M$ -37.98M$ -28.60M$ -23.97M$ -14.76M
Per Share Metrics
Basic EPS
$ -1.22$ -3.11$ -4.05$ -4.32$ -7.45
Diluted EPS
$ -1.20$ -3.11$ -4.05$ -4.32$ -7.45
Weighted Average Shares Outstanding
36.62M 12.22M 7.06M 5.55M 1.98M
Weighted Average Shares Outstanding (Diluted)
37.14M 12.22M 7.06M 5.55M 1.98M
Currency in USD

Cellectar Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis